share_log

JMP Securities Maintains Market Outperform on Aura Biosciences, Lowers Price Target to $19

Benzinga ·  Nov 10, 2023 14:40

JMP Securities analyst Jonathan Wolleben maintains Aura Biosciences (NASDAQ:AURA) with a Market Outperform and lowers the price target from $21 to $19.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment